Acta Med. 2010, 53: 139-145
https://doi.org/10.14712/18059694.2016.73
Visual Functions after Laser Photocoagulation in Central Serous Chorioretinopathy
References
1. NV, Gürlü VP, Esquin H. Long-term macular function in eyes with central serous chorioretinopathy. Clin Experiment Ophthalmol 2005; 33(4): 369–372.
<https://doi.org/10.1111/j.1442-9071.2005.01027.x>
2. D, Kondrova J, Stibor V, Bartosova L, Rousova A. Changes in psychovisual function after central serous chorioretinopathy. Cesk Slov Oftalmol 1998; 54(3):166–173.
3. H, Pörksen E, Klatt C, et al. Selective retina therapy in patients with central serous chorioretinopathy. Graefes Arch Clin Exp Ophthalmol. 2006; 244(12): 1638–1645.
<https://doi.org/10.1007/s00417-006-0368-5>
4. FL, Krasoff A, Bresnick GH, Bailey I. New visual acuity charts for clinical research. Am J Ophthalmol 1982; 94:91–96.
<https://doi.org/10.1016/0002-9394(82)90197-0>
5. JC, Thompson HS, Han DP, Brown CK. Visual function abnormalities in central serous retinopathy. Arch Ophthalmol 1984; 102(9):1299–1302.
<https://doi.org/10.1001/archopht.1984.01040031049021>
6. L, Frisén M. How good is normal visual acuity? Albrecht Von Graefes Arch Klin Exp Ophthalmol. 1981p; 215(3):149–157.
<https://doi.org/10.1007/BF00413146>
7. JDM. Pathogenesis of disciform detachment of the neuroepithelium, Idiopathic central serous chorioretinopathy. Am J Ophthalmol 1967; 63:587–615.
8. CR 2nd, Kandel GL, Bedell HR. The minimum angle of resolution vs angle of regard function as measured with different targets. Ophthalmic Physiol Opt. 1981; 1: 3–13.
<https://doi.org/10.1016/0275-5408(81)90056-9>
9. DC, Bach M, Brigell M. ISCEV guidelines for clinical multifocal electroretinography (2007 edition). Doc Ophthalmol 2008; 116(1): 1–11.
<https://doi.org/10.1007/s10633-007-9089-2>
<PubMed>
10. AV, Marmor MF. Multifocal electroretinogram abnormalities persist following resolution of central serous chorioretinopathy. Arch Ophthalmol 2000; 118(9):1211–1215.
<https://doi.org/10.1001/archopht.118.9.1211>
11. T, Yannuzzi LA, Spaide RF, Borodoker N, Carvalho CA, Negrao S. Cystoid macular degeneration in chronic central serous chorioretinopathy. Retina 2003; 23(1): 1–7.
<https://doi.org/10.1097/00006982-200302000-00001>
12. PK, Rana DD, Tewari HK, Azad RU, Talvar D. Evaluation of visual function following argon laser photocoagulation in central serous retinopathy. Ophthal Surg Las 1997; 28: 8693–8697.
13. P, Laatikainen L, von Dickhoff K. Contrast sensitivity after resolution of central serous retinopathy. Graefes Arch Clin Exp Ophthalmol 1994; 232(8): 473–476.
<https://doi.org/10.1007/BF00195356>
14. TY, Lai RY, Ngai JW, Chan WM, Li H, Lam DS. First and second-order kernel multifocal electroretinography abnormalities in acute central serous chorioretinopathy. Doc Ophthalmol 2008; 116(1): 29–40.
<https://doi.org/10.1007/s10633-007-9075-8>
15. H, Hejcmanová D, Peregrin J. Reproducibility of contrast sensitivity measurements. Cesk Slov Oftalmol 1996; 52: 52–57.
16. P. [Evaluation of the desaturated Panel D-15. I. Method of quantification and normal scores]. J Fr Ophtalmol 1986; 9(12): 843–847.
17. P, Williams C. Argon laser photocoagulation in the treatment of central serous retinopathy. Br J Ophthalmol 1979; 63(10): 674–677.
<https://doi.org/10.1136/bjo.63.10.674>
<PubMed>
18. N, Zhang C. Contrast sensitivity study in fellow eyes of patients with central serous chorioretinopathy. Zhongguo Yi Xue Ke Xue Yuan Xue Bao 1992; 14(2): 85–88.
19. TH, Mäntyjärvi MI. Contrast sensitivity in patients recovered from central serous chorioretinopathy. Int Ophthalmol 1999; 23(1): 31–35.
<https://doi.org/10.1023/A:1006496615006>
20. TH, Tuppurainen KT, Mäntyjärvi MI. Color vision defects after central serous chorioretinopathy. Retina 2000; 20(6): 633–637.
<https://doi.org/10.1097/00006982-200011000-00008>
21. MF, Tan F. Central serous chorioretinopathy: bilateral multifocal electroretinographic abnormalities. Arch Ophthalmol 1999; 117(2): 184–188.
<https://doi.org/10.1001/archopht.117.2.184>
22. MF, Zrenner E. Standard for clinical electroretinography (1999 update). International Society for Clinical Electrophysiology of Vision. Doc Ophthalmol 1998–1999; 97(2): 143–156.
<https://doi.org/10.1023/A:1002016531591>
23. MF, Fulton AB, Holder GE, Miyake Y, Brigell M, Bach M. International Society for Clinical Electrophysiology of Vision. ISCEV Standard for full-field clinical electroretinography (2008 update). Doc Ophthalmol. 2009; 118(1): 69–77.
<https://doi.org/10.1007/s10633-008-9155-4>
24. MF, Hood DC, Keating D, Kondo M, Seeliger MW, Miyake Y. Guidelines for basic multifocal electroretinography (mfERG). Doc Ophthalmol 2003; 106(2): 105–115.
<https://doi.org/10.1023/A:1022591317907>
25. Y, Shiroyama N, Ota I, Horiguchi M. Local macular electroretinographic responses in idiopathic central serous chorioretinopathy. Am J Ophthalmol 1988; 106(5): 546–550.
<https://doi.org/10.1016/0002-9394(88)90583-1>
26. M, Brouzas D, Koutsandrea C. Assessment of central serous chorioretinopathy by optical coherence tomography and multifocal electroretinography. Ophthalmologica 2007; 221(5): 292–298.
<https://doi.org/10.1159/000104758>
27. Y, Masanori H, Sasahara M. Three-dimensional imaging of the foveal photoreceptor layer in the sentral serous chorioretinopathy using high-speed optical coherence tomography. Ophthalmology 2007; 114(12): 2197–2207.
<https://doi.org/10.1016/j.ophtha.2007.02.015>
28. H, Karacorlu SA, Senturk F, Karacorlu M, Uysal O. Eye. 2008; 22(2): 204–208.
<https://doi.org/10.1038/sj.eye.6702563>
29. FC, de la Longrais RR, Ravera G, et al. The foveal photoreceptor layer and visual acuity loss in central serous chorioretinopathy. Am J Ophthalmol. 2005; 139(1): 87–99.
<https://doi.org/10.1016/j.ajo.2004.08.037>
30. DM, Ilstrup D. Direct, indirect, and laser photocoagulation in the management of central serous chorioretinopathy. Am J Ophthalmol 1983; 95: 457–466.
<https://doi.org/10.1016/0002-9394(83)90265-9>
31. J, Frisén L. Contrast sensitivity in macular disease. A preliminary report. Acta Ophthalmol (Copenh) 1977; 55: 507–514.
<https://doi.org/10.1111/j.1755-3768.1977.tb06128.x>
32. EE, Tran D. The field topography of ERG components in man-I. The photopic luminance response. Vision Res 1992; 32(3): 433–446.
<https://doi.org/10.1016/0042-6989(92)90235-B>
33. K, Hasegawa S, Usui T, et al. Multifocal electroretinogram in patients with central serous chorioretinopathy. Jpn J Ophthalmol 2002; 46(3): 308–314.
<https://doi.org/10.1016/S0021-5155(02)00477-X>
34. M, Boyer DS, Thomas EL. Chronic central serous chorioretinopathy: photodynamic therapy. Am J Ophthalmol 2004; 137: 1073–1080.
<https://doi.org/10.1016/j.ajo.2004.01.043>
35. TS, Szlyk JP, Fishman GA, Gieser JP, Seiple W. Localized retinal dysfunction in central serous chorioretinopathy as measured using the multifocal electroretinogram. Ophthalmology 2002; 109(7): 1243–1250.
<https://doi.org/10.1016/S0161-6420(02)01065-5>
36. AJ, King-Smith PE. A quantitative scoring technique for panel tests of color vision. Invest Ophthalmol Vis Sci 1988; 29(1): 50–63.
37. EY, Robertson DM. The long-term outcome of central serous chorioretinopathy. Arch Ophthalmol 1996; 114: 689–692.
<https://doi.org/10.1001/archopht.1996.01100130681007>


